HMGB1 in systemic lupus Erythematosus: Its role in cutaneous lesions development

Autoimmunity Reviews

Volumn 9, Issue 10, 2010, Pages 661-665

  Abdulahad, D A ^a   Westra, J ^a   Limburg, P C ^a   Kallenberg, C G M ^a   Bijl, M ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Apoptosis; HMGB1; RAGE; SLE; TLRs; Ultraviolet radiation

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ADVANCED GLYCATION END PRODUCT RECEPTOR; AUTOANTIBODY; DNA ANTIBODY; FC RECEPTOR; HIGH MOBILITY GROUP B1 PROTEIN; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 9;

APOPTOSIS; CELL ACTIVATION; HUMAN; IMMUNOGENICITY; IMMUNOPATHOGENESIS; PATHOPHYSIOLOGY; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN SECRETION; REVIEW; SKIN INFLAMMATION; SKIN LUPUS ERYTHEMATOSUS; SYSTEMIC LUPUS ERYTHEMATOSUS;

ANIMALS; ANTIGENS, NEOPLASM; APOPTOSIS; CHROMATIN; HISTONES; HMGB1 PROTEIN; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MITOGEN-ACTIVATED PROTEIN KINASES; PHAGOCYTOSIS; PROTEIN BINDING; SKIN; TOLL-LIKE RECEPTORS;

EID: 77955276763     PISSN: 15689972     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.autrev.2010.05.015     Document Type: Review

References (41)

1. Merenmies J., Pihlaskari R., Laitinen J., Wartiovaara J., Rauvala H. 30-kDa heparin-binding protein of brain (amphoterin) involved in neurite outgrowth. Amino acid sequence and localization in the filopodia of the advancing plasma membrane. J Biol Chem 1991, 266:16722-16729.
2. Einck L., Bustin M. The intracellular distribution and function of the high mobility group chromosomal proteins. Exp Cell Res 1985, 156:295-310.
3. Landsman D., Bustin M. A signature for the HMG-1 box DNA-binding proteins. Bioessays 1993, 15:539-546.
4. Melvin V.S., Edwards D.P. Coregulatory proteins in steroid hormone receptor action: the role of chromatin high mobility group proteins HMG-1 and -2. Steroids 1999, 64:576-586.
5. Harris H.E., Raucci A. Alarmin(g) news about danger: workshop on innate danger signals and HMGB1. EMBO Rep 2006, 7:774-778.
6. Andersson U., Wang H., Palmblad K., Aveberger A.C., Bloom O., Erlandsson-Harris H., et al. High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes. J Exp Med 2000, 192:565-570.
7. Kokkola R., Andersson A., Mullins G., Ostberg T., Treutiger C.J., Arnold B., et al. RAGE is the major receptor for the proinflammatory activity of HMGB1 in rodent macrophages. Scand J Immunol 2005, 61:1-9.
8. Fiuza C., Bustin M., Talwar S., Tropea M., Gerstenberger E., Shelhamer J.H., et al. Inflammation-promoting activity of HMGB1 on human microvascular endothelial cells. Blood 2003, 101:2652-2660.
9. Rouhiainen A., Kuja-Panula J., Wilkman E., Pakkanen J., Stenfors J., Tuominen R.K., et al. Regulation of monocyte migration by amphoterin (HMGB1). Blood 2004, 104:1174-1182.
10. Yu M., Wang H., Ding A., Golenbock D.T., Latz E., Czura C.J., et al. HMGB1 signals through toll-like receptor (TLR) 4 and TLR2. Shock 2006, 26:174-179.
11. Hreggvidsdottir H.S., Ostberg T., Wahamaa H., Schierbeck H., Aveberger A.C., Klevenvall L., et al. The alarmin HMGB1 acts in synergy with endogenous and exogenous danger signals to promote inflammation. J Leukoc Biol 2009, 86:655-662.
12. Sha Y., Zmijewski J., Xu Z., Abraham E. HMGB1 develops enhanced proinflammatory activity by binding to cytokines. J Immunol 2008, 180:2531-2537.
13. Tian J., Avalos A.M., Mao S.Y., Chen B., Senthil K., Wu H., et al. Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE. Nat Immunol 2007, 8:487-496.
14. Dumitriu I.E., Baruah P., Valentinis B., Voll R.E., Herrmann M., Nawroth P.P., et al. Release of high mobility group box 1 by dendritic cells controls T cell activation via the receptor for advanced glycation end products. J Immunol 2005, 174:7506-7515.
15. Manfredi A.A., Capobianco A., Esposito A., De Cobelli F., Canu T., Monno A., et al. Maturing dendritic cells depend on RAGE for in vivo homing to lymph nodes. J Immunol 2008, 180:2270-2275.
16. Zhu X.M., Yao Y.M., Liang H.P., Xu S., Dong N., Yu Y., et al. The effect of high mobility group box-1 protein on splenic dendritic cell maturation in rats. J Interferon Cytokine Res 2009, 29:677-686.
17. Campana L., Bosurgi L., Bianchi M.E., Manfredi A.A., Rovere-Querini P. Requirement of HMGB1 for stromal cell-derived factor-1/CXCL12-dependent migration of macrophages and dendritic cells. J Leukoc Biol 2009, 86:609-615.
18. Zhang Y., Yao Y.M., Yu Y., Wu Y., Sheng Z.Y. Influence of high-mobility group box 1 protein on the correlation between regulatory T cells and CD4+ CD25- T cells of spleen in mice. Zhonghua Wai Ke Za Zhi 2008, 46:217-220.
19. Kazama H., Ricci J.E., Herndon J.M., Hoppe G., Green D.R., Ferguson T.A. Induction of immunological tolerance by apoptotic cells requires caspase-dependent oxidation of high-mobility group box-1 protein. Immunity 2008, 29:21-32.
20. Wahamaa H., Vallerskog T., Qin S., Lunderius C., LaRosa G., Andersson U., et al. HMGB1-secreting capacity of multiple cell lineages revealed by a novel HMGB1 ELISPOT assay. J Leukoc Biol 2007, 81:129-136.
21. Chen G., Li J., Ochani M., Rendon-Mitchell B., Qiang X., Susarla S., et al. Bacterial endotoxin stimulates macrophages to release HMGB1 partly through. J Leukoc Biol 2004, 76:994-1001.
22. Rendon-Mitchell B., Ochani M., Li J., Han J., Wang H., Yang H., et al. IFN-gamma induces high mobility group box 1 protein release partly through a TNF-dependent mechanism. J Immunol 2003, 170:3890-3897.
23. Wang H., Vishnubhakat J.M., Bloom O., Zhang M., Ombrellino M., Sama A., et al. Proinflammatory cytokines (tumor necrosis factor and interleukin 1) stimulate release of high mobility group protein-1 by pituicytes. Surgery 1999, 126:389-392.
24. Bell C.W., Jiang W., Reich C.F., Pisetsky D.S. The extracellular release of HMGB1 during apoptotic cell death. Am J Physiol Cell Physiol 2006, 291:C1318-C1325.
25. Scaffidi P., Misteli T., Bianchi M.E. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 2002, 418:191-195.
26. Bonaldi T., Talamo F., Scaffidi P., Ferrera D., Porto A., Bachi A., et al. Monocytic cells hyperacetylate chromatin protein HMGB1 to redirect it towards secretion. EMBO J 2003, 22:5551-5560.
27. Youn J.H., Shin J.S. Nucleocytoplasmic shuttling of HMGB1 is regulated by phosphorylation that redirects it toward secretion. J Immunol 2006, 177:7889-7897.
28. Urbonaviciute V., Furnrohr B.G., Meister S., Munoz L., Heyder P., De Marchis F., et al. Induction of inflammatory and immune responses by HMGB1-nucleosome complexes: implications for the pathogenesis of SLE. J Exp Med 2008, 205:3007-3018.
29. Urbonaviciute V., Meister S., Furnrohr B.G., Frey B., Guckel E., Schett G., et al. Oxidation of the alarmin high-mobility group box 1 protein (HMGB1) during apoptosis. Autoimmunity 2009, 42:305-307.
30. Baumann I., Kolowos W., Voll R.E., Manger B., Gaipl U., Neuhuber W.L., et al. Impaired uptake of apoptotic cells into tingible body macrophages in germinal centers of patients with systemic lupus erythematosus. Arthritis Rheum 2002, 46:191-201.
31. Bijl M., Reefman E., Horst G., Limburg P.C., Kallenberg C.G. Reduced uptake of apoptotic cells by macrophages in systemic lupus erythematosus: correlates with decreased serum levels of complement. Ann Rheum Dis 2006, 65:57-63.
32. Qing X., Pitashny M., Thomas D.B., Barrat F.J., Hogarth M.P., Putterman C. Pathogenic anti-DNA antibodies modulate gene expression in mesangial cells: involvement of HMGB1 in anti-DNA antibody-induced renal injury. Immunol Lett 2008, 121:61-73.
33. Li J., Xie H., Wen T., Liu H., Zhu W., Chen X. Expression of high mobility group box chromosomal protein 1 and its modulating effects on downstream cytokines in systemic lupus erythematosus. J Rheumatol 2010, 37:689-691.
34. Avalos A.M., Kiefer K., Tian J., Christensen S., Shlomchik M., Coyle A.J., et al. RAGE-independent autoreactive B cell activation in response to chromatin and HMGB1/DNA immune complexes. Autoimmunity 2010, 43:103-110.
35. Liu G., Wang J., Park Y.J., Tsuruta Y., Lorne E.F., Zhao X., et al. High mobility group protein-1 inhibits phagocytosis of apoptotic neutrophils through binding to phosphatidylserine. J Immunol 2008, 181:4240-4246.
36. Hayashi A., Nagafuchi H., Ito I., Hirota K., Yoshida M., Ozaki S. Lupus antibodies to the HMGB1 chromosomal protein: epitope mapping and association with disease activity. Mod Rheumatol 2009, 19:283-292.
37. Tsuchida T. Classification of lupus erythematosus based upon Japanese patients. Autoimmun Rev 2009, 8:453-455.
38. Arai S., Katsuoka K. Clinical entity of Lupus erythematosus panniculitis/lupus erythematosus profundus. Autoimmun Rev 2009, 8:449-452.
39. Bijl M., Reefman E., Limburg P.C., Kallenberg C.G. Inflammatory clearance of apoptotic cells after UVB challenge. Autoimmunity 2007, 40:244-248.
40. Barkauskaite V., Ek M., Popovic K., Harris H.E., Wahren-Herlenius M., Nyberg F. Translocation of the novel cytokine HMGB1 to the cytoplasm and extracellular space coincides with the peak of clinical activity in experimentally UV-induced lesions of cutaneous lupus erythematosus. Lupus 2007, 16:794-802.
41. Popovic K., Ek M., Espinosa A., Padyukov L., Harris H.E., Wahren-Herlenius M., et al. Increased expression of the novel proinflammatory cytokine high mobility group box chromosomal protein 1 in skin lesions of patients with lupus erythematosus. Arthritis Rheum 2005, 52:3639-3645.